Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples